Allergic reaction to topical eyedrops

被引:79
作者
Baudouin, C
机构
[1] Quinze Vingts Natl Ophthalmol Hosp, Dept Ophthalmol, F-75012 Paris, France
[2] Univ Versailles, Paris Quest Sch Med, Paris, France
[3] Ambroise Pare Hosp, AP HP, Boulogne, France
[4] Univ Paris 05, INSERM U598, Inst Biomed Cordeliers, Paris, France
关键词
allergy; benzalkonium chloride; drugs; eyedrops; glaucoma; preservative; toxicity;
D O I
10.1097/01.all.0000183112.86181.9e
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review: To examine recently published papers dealing with drug-induced allergic reactions. As allergy is only one possible mechanism, this review was extended to all reports or studies describing allergic, inflammatory or toxic effects related to eyedrops since 2004. Recent findings: These studies were first classified into clinical reports or surveys, experimental works and biological studies showing drug-induced effects on the ocular surface or eyelids. Studies aimed at determining the role of preservatives or comparing preservative-free and preserved eyedrops were further analysed separately. Summary: Reports on allergic or toxic reactions of eyedrops are published repeatedly. The reports raising the most important issues are those concerning antiglaucoma drugs. They consistently describe inflammatory reactions at the conjunctival level, with strong evidence that preservative is a major source of toxicity for the ocular surface.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 32 条
[1]   Ocular surface inflammatory changes induced by topical antiglaucoma drugs -: Human and animal studies [J].
Baudouin, C ;
Pisella, PJ ;
Fillacier, K ;
Goldschild, M ;
Becquet, F ;
De Saint Jean, M ;
Béchetoille, A .
OPHTHALMOLOGY, 1999, 106 (03) :556-563
[2]   Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term [J].
Baudouin, C ;
Hamard, P ;
Liang, H ;
Creuzot-Garcher, C ;
Bensoussan, L ;
Brignole, F .
OPHTHALMOLOGY, 2004, 111 (12) :2186-2192
[3]   Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate [J].
Becker, HJ ;
Walton, RC ;
Diamant, JI ;
Zegans, ME .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (07) :1063-1066
[4]   A comparative study of the ocular tolerance after administration of anti-allergic eye drops with or without a preservative [J].
Beden, C ;
Helleboid, L ;
Marmouz, F ;
Liard, F .
THERAPIE, 2004, 59 (02) :259-264
[5]   ADVERSE-EFFECTS OF TOPICAL ANTIGLAUCOMATOUS MEDICATIONS ON THE CONJUNCTIVA [J].
BRAODWAY, D ;
GRIERSON, I ;
HITCHINGS, R .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (09) :590-596
[6]   ADVERSE-EFFECTS OF TOPICAL ANTIGLAUCOMA MEDICATION .2. THE OUTCOME OF FILTRATION SURGERY [J].
BROADWAY, DC ;
GRIERSON, I ;
OBRIEN, C ;
HITCHINGS, RA .
ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (11) :1446-1454
[7]  
Debbasch C, 2001, INVEST OPHTH VIS SCI, V42, P2525
[8]   Effects of topical antiglaucoma drugs on apoptosis rates of conjunctival epithelial cells in glaucoma patients [J].
Dogan, AL ;
Orhan, M ;
Söylemezoglu, F ;
Irkeç, M ;
Bozkurt, B .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 32 (01) :62-66
[9]  
Donnenfeld E, 2004, CURR MED RES OPIN, V20, P1753, DOI 10.1185/030079904X5959
[10]   Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery [J].
Eleftheriadis, H ;
Cheong, M ;
Sandeman, S ;
Syam, PP ;
Brittain, P ;
Klintworth, GK ;
Lloyd, A ;
Liu, C .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (03) :299-305